COX-2 overexpression has been shown to stabilise survivin in nonsmall cell lung cancer by preventing its ubiquitination (Krysan et al, 2004) leading to the decreased rates of apoptosis seen in COX-2 overexpressing lung tumours. The gene discussed is PTGS2; the disease is lung cancer.